Replies to post #40585 on Langlui's Big Board and Options Plays

[jaybird249]

GNVC 16 MM Volume Next AGEN DNDN $.84 + $.14 pancreatic cancer drug INCREASED SURVIVAL BY 8 MONTHS. For pancreatic CA that is a revolutionary result, should have made the stock price $5. Compare Tarceva, which added 15 days to overall survival over 6 months.